15th Open Scientific EIP Symposium on Immunogenicity of Biopharmaceuticals

April 22 – 24, 2024

Altis Grand Hotel

Rua Castilho 11

1269-072 Lisbon, Portugal

We look forward to meeting you at EIP. 

Request a meeting with our team in Lisbon to learn how we help our clients advance their therapeutic drug programs.

Schedule a Meeting

Speak with our scientific experts onsite to discuss your project.

BioAgilytix Presentations at EIP

Phase-Appropriate Implementation of a Domain Specificity Strategy

Presenter: Matthias Reichel M.Sc. – Principal Investigator
Thursday, 23 April 2024

The IVDR and its Impact on Clinical Immunogenicity Assay Development

Presenter: Robert Nelson PhD – Scientific Officer
Thursday, 23 April 2024

About the event

The European Immunogenicity Platform (EIP) acts as a central meeting place for European biopharmaceutical companies and scientific experts active in the area of immunogenicity. Its mission is to increase knowledge and expertise in the field of immunogenicity, fostered by close interactions between industry and scientific advisors. EIP represents companies, institutes and professionals involved in research, development, testing, validation, application, production or marketing of immunogenicity assessment tools, as well as those servicing the biotechnology community

Partner with BioAgilytix for your immunogenicity project  

BioAgilytix’s scientists are experts in the assessment of humoral and cellular immune responses to biotherapeutic modalities. When you partner with BioAgilytix you are connected to:

  • Regulated data to support immunogenicity risk assessment for all biotherapeutics
  • Support forglobal trials with labs in the U.S., Europe, and Australia
  • Over 10 years of experience in immunogenicity risk assessment
  • Experience in supporting studies in various species, including rodents, humans, and non-human primates

BioAgilytix has proven experience assessing immunogenicity for therapeutic modalities, including:

  • ADA and NAb testing for large molecules and ATMPs
  • Assays for detection of cellular immunogenicity
  • Measurements of cytokine production
  • Reagent labeling and oversight of surrogate positive control antibody generation
  • Statistical analysis to support cut point generation

Schedule a meeting with our experts online

Speak with our team about how the combination of world-class scientific expertise, outstanding project management, and superior regulatory insight can expedite your advanced therapeutic. You can also fill out the form, and an expert will reach out to schedule a meeting with you onsite.